Evelyn_mq Lee

Dr. Evelyn_mq Lee

1. Centre for Economic Impacts of Genomic Medicine, Macquarie University, North Ryde, NSW 2109, Australia
+1
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2014 in Human Reproduction
Verified
Journal Article
Open access
PDF file
ELEvelyn_mq Lee
Evelyn_mq Lee
PIPeter Illingworth
Peter Illingworth
LWLeeanda Wilton
Leeanda Wilton
GCGeorgina Mary Chambers
Georgina Mary Chambers
Is preimplantation genetic diagnosis for aneuploidy (PGD-A) with analysis of all chromosomes during assisted reproductive technology (ART) clinically and cost effective? The majority of published studies comparing a strategy of PGD-A with morphologically assessed embryos have reported a higher implantation rate per embryo using PGD-A, but insufficient data has been presented to evaluate the clinical and cost-effectiveness of PGD-A in the clinical setting. Aneuploidy is a leading cause of implantation failure, miscarriage and congenital abnormalities in humans, and a significant cause of ART failure. Preclinical evidence of PGD-A indicates that the selection and transfer of euploid embryos during ART should improve clinical outcomes. A systematic review of the literature was performed for full text English language articles using MEDLINE, EMBASE, SCOPUS, Cochrane Library databases, NHS Economic Evaluation Database and EconLit. The Downs and Black scoring checklist was used to assess the quality of studies. Clinical effectiveness was measured in terms of pregnancy, live birth and miscarriage rates. Nineteen articles meeting the inclusion criteria, comprising three RCTs in young and good prognosis patients and 16 observation studies were identified. Five of the observational studies included a control group of patients where embryos were selected based on morphological criteria (matched cohort studies). Of the five studies that included a control group and reported implantation rates, four studies (including two RCTs) demonstrated improved implantation rates in the PGD-A group. Of the eight studies that included a control group, six studies (including two RCTs) reported significantly higher pregnancy rates in the PGD-A group, and in the remaining two studies, equivalent pregnancies rates were reported despite fewer embryos being transferred in the PGD-A group. The three RCTs demonstrated benefit in young and good prognosis patients in terms of clinical pregnancy rates and the use of single embryo transfer. However, studies relating to patients of advanced maternal age, recurrent miscarriage and implantation failure were restricted to matched cohort studies, limiting the ability to draw meaningful conclusions. Relevant studies may have been missed and findings from RCTs currently being undertaken could not be included. Given the uncertain role of PGD-A techniques, high-quality experimental studies using intention-to-treat analysis and cumulative live birth rates including the comparative outcomes from remaining cryopreserved embryos are needed to evaluate the overall role of PGD-A in the clinical setting. It is only in this way that the true contribution of PGD-A to ART can be understood. No specific funding was used to undertake this study. Evelyn Lee does not report any conflict of interest. Associate Professor Illingworth is an employee of and a shareholder in Virtus Health which is a provider of clinical preimplantation genetic services to patients in Australia Dr Leeanda Wilton is an employee of and a shareholder in Virtus Health which is a provider of PGD services in Australia Dr Chambers previously received grant support to her institution from the Australian Government, Australian Research Council (ARC) Linkage Grant No. LP1002165; ARC Linkage Grant Partner Organisations were IVF Australia, Melbourne IVF and Queensland Fertility Group. NA.

1 August 2018 in The Lancet HIV
Verified
Journal Article
Closed access
MHMartin Holt
Martin Holt
TLToby Lea
Toby Lea
LMLimin Mao
Limin Mao
JKJohann Kolstee
Johann Kolstee
IZIryna Zablotska
Iryna Zablotska
GPGarrett Prestage
Garrett Prestage

1 November 2014 in JAMA Pediatrics
Verified
Journal Article
Open access
PDF file
GCGeorgina M. Chambers
Georgina M. Chambers
VHVan Phuong Hoang
Van Phuong Hoang
ELEvelyn_mq Lee
Evelyn_mq Lee
MHMichele Hansen
Michele Hansen
ESElizabeth A. Sullivan
Elizabeth A. Sullivan
MCMichael Chapman
Michael Chapman
The unprecedented increase in twin, triplet, and other higher-order multiple (HOM) births during the past 3 decades is a major public health concern worldwide. In 2011 in the United States, 131 269 infants were born in twin deliveries, representing a twin birth rate of 33.2 per 1000 births, a 76% increase from 1980 to 2011 according to national statistics.1 Even more striking, the rate of HOM births in the United States rose by 500% from 1980 (0.37 per 1000 births) to 1998 (1.94 per 1000 births) but has since trended downward to 1.37 per 1000 births in 2011 (5417 births).1

29 August 2016 in Sexual Health
Verified
Journal Article
Open access
PDF file
MHMartin Holt
Martin Holt
TLToby Lea
Toby Lea
LMLimin Mao
Limin Mao
IZIryna Zablotska
Iryna Zablotska
ELEvelyn_mq Lee
Evelyn_mq Lee
GPGarrett Prestage
Garrett Prestage
Background: In Australia, the preventative use of antiretroviral drugs [pre-exposure prophylaxis (PrEP) and treatment as prevention] is being embraced to protect individuals at high risk of HIV and reduce onward transmission. Methods: The adaptation of a behavioural surveillance system, the Gay Community Periodic Surveys, was reviewed to monitor the uptake and effect of new prevention strategies in Australia’s primary HIV-affected population (gay and bisexual men, GBM). The national trends in key indicators during 2000–15 were reviewed and a new measure to take account of antiretroviral-based prevention was developed. Results: Between 2000 and 2015, there were significant increases (P < 0.001) in annual HIV testing (56.1–64.8%), condomless sex with casual partners (26.8—38.8%) and the proportion of HIV-positive men on HIV treatment (72.5–88.4%) and with an undetectable viral load (73.7–94.7%). The proportion of casual partners who were HIV negative, not on PrEP and who engaged in receptive condomless sex also increased between 2000 and 2015 from 12.8 to 19.3%. Two scenarios anticipating the effect of PrEP highlighted the need to target GBM who engage in receptive condomless sex while also sustaining condom use at a population level. Conclusions: Behavioural surveillance can be successfully adapted to follow the effect of antiretroviral-based prevention. It is anticipated that HIV testing and HIV treatment will continue to increase among Australian GBM, but to prevent new infections, intervention in the growing proportion of GBM who have condomless sex with casual partners is needed. For PrEP to have its desired effect, condom use needs to be sustained.

6 January 2020 in JAIDS Journal of Acquired Immune Deficiency Syndromes
Verified
Journal Article
Closed access
MHMartin Holt
Martin Holt
ELEvelyn_mq Lee
Evelyn_mq Lee
TLToby Lea
Toby Lea
BBBenjamin Bavinton
Benjamin Bavinton
TBTim Broady
Tim Broady
JWJohn de Wit
John de Wit
Background: HIV prevention cascades can assist in monitoring the implementation of prevention methods like preexposure prophylaxis (PrEP). We developed 2 PrEP cascades for Australia's primary HIV-affected population, gay and bisexual men. Methods: Data were drawn from 2 national, repeated, cross-sectional surveys (the Gay Community Periodic Surveys and PrEPARE Project). One cascade had 3 steps, and the other had 7 steps. Trends over time were assessed using logistic regression. For the most recent year, we identified the biggest drop between steps in each cascade and compared the characteristics of men between the 2 steps using multivariate logistic regression. Results: Thirty-nine thousand six hundred and seventy non–HIV-positive men participated in the Periodic Surveys during 2014–2018. PrEP eligibility increased from 28.1% (1901/6762) in 2014 to 37.3% (2935/7878) in 2018 (P < 0.001), awareness increased from 29.6% (563/1901) to 87.1% (2555/2935; P < 0.001), and PrEP use increased from 3.7% (21/563) to 45.2% (1155/2555; P < 0.001). Of 1038 non–HIV-positive men in the PrEPARE Project in 2017, 54.2% (n = 563) were eligible for PrEP, 97.2% (547/563) were aware, 67.6% (370/547) were willing to use PrEP, 73.5% (272/370) had discussed PrEP with a doctor, 78.3% (213/272) were using PrEP, 97.2% (207/213) had recently tested, and 75.8% (157/207) reported reduced HIV concern and increased pleasure because of PrEP. The break point analyses indicated that PrEP coverage was affected by geographical availability, education level, employment, and willingness to use PrEP. Conclusions: PrEP eligibility, awareness, and use have rapidly increased among Australian gay and bisexual men. The cascades identify disparities in uptake by eligible men as a result of socioeconomic factors and PrEP's acceptability.

5 May 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JIJohn Nkwoma Inekwe
John Nkwoma Inekwe
ELEvelyn_mq Lee
Evelyn_mq Lee
The postpartum period is a challenging transition period with almost one in ten mothers experiencing depression after childbirth. Perceived social support is associated with mental health. Yet empirical evidence regarding the causal effects of social support on postpartum mental health remains scarce. In this paper, we used a nationally representative panel data of women to examine causality between perceived social support and postpartum mental health. We used fixed-effect method and included dependent variable lags to account for past mental health condition before birth (i.e., the pre-pregnancy and prenatal periods). The study also used an instrumental variable approach to address endogeneity. We find a declining trend in postpartum mental health between 2002 to 2018. Our study also showed that past mental health (i.e., before childbirth) is positively correlated with postpartum mental health. A universal routine mental health screening for expectant and new mothers should remain a key priority to ensure mental wellbeing for the mothers and their infants.